Home › Funds › Citigroup Inc › TXMD
Citigroup Inc position in TXMD
THERAPEUTICSMD INC · Health Care
Latest position (Q2 2026)64 sh
Reported value held$141
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 77.99K | $58.00K | New |
| Q4 2021 | 112.85K | $40.00K | Add |
| Q1 2022 | 22.93K | $9.00K | Reduce |
| Q2 2022 | 69 | $1.00K | Reduce |
| Q2 2025 | 203 | $235 | New |
| Q3 2025 | 1 | $1 | Reduce |
| Q4 2025 | 1 | $2 | Hold |
| Q2 2026 | 64 | $141 | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TXMD
- Vanguard Group 397.06K sh · $647.20K · Q4 2025
- Renaissance Technologies 146.60K sh · $323.98K · Q2 2026
- Morgan Stanley 129.22K sh · $285.57K · Q2 2026
- BlackRock Inc 115.14K sh · $254.47K · Q2 2026
- Geode Capital Management 105.85K sh · $233.99K · Q2 2026
- Citadel Advisors 86.09K sh · $190.27K · Q2 2026
- Northern Trust Corp 18.56K sh · $41.01K · Q2 2026
- UBS Group AG 4.66K sh · $10.30K · Q2 2026
- JPMorgan Chase & Co 293 sh · $657 · Q2 2026
- Wells Fargo & Co 115 sh · $254 · Q2 2026